Neither peptide is FDA-approved for performance or injury treatment
Week 34 (Continuing 0.25 mg): For many patients, gastrointestinal symptoms begin to improve or stabilise during this period as physiological adaptation occurs
If tiredness continues beyond the initial months of treatment, becomes progressively worse, or significantly impairs daily functioning, it may indicate inadequate nutrition, dehydration, electrolyte disturbances, uncontrolled diabetes, thyroid dysfunction, anaemia, or other medical conditions requiring investigation
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flatno hidden flat per-compound pricing
The plateau feels like failure